Myotonia congenita: Difference between revisions
No edit summary Tag: Manual revert |
CSV import |
||
| Line 1: | Line 1: | ||
{{Infobox medical condition | |||
| name = Myotonia congenita | |||
| synonyms = [[Thomsen disease]], [[Becker disease]] | |||
| field = [[Neurology]] | |||
| symptoms = Muscle stiffness, difficulty relaxing muscles | |||
| onset = Childhood or adolescence | |||
| duration = Lifelong | |||
| causes = Mutations in the [[CLCN1]] gene | |||
| risks = Family history | |||
| diagnosis = [[Clinical examination]], [[genetic testing]] | |||
| differential = [[Myotonic dystrophy]], [[paramyotonia congenita]] | |||
| treatment = [[Physical therapy]], [[medication]] such as [[mexiletine]] | |||
| frequency = Rare | |||
}} | |||
'''Myotonia Congenita''' is a [[neuromuscular disorder]] characterized by the slow relaxation of the [[muscles]] after voluntary contraction or electrical stimulation. This condition is present from early childhood, but symptoms can be mild. Myotonia Congenita is caused by mutations in the [[CLCN1 gene]] and can be inherited in an autosomal dominant or autosomal recessive manner. | '''Myotonia Congenita''' is a [[neuromuscular disorder]] characterized by the slow relaxation of the [[muscles]] after voluntary contraction or electrical stimulation. This condition is present from early childhood, but symptoms can be mild. Myotonia Congenita is caused by mutations in the [[CLCN1 gene]] and can be inherited in an autosomal dominant or autosomal recessive manner. | ||
== Signs and Symptoms == | == Signs and Symptoms == | ||
The hallmark of Myotonia Congenita is muscle stiffness (myotonia) that worsens after periods of rest and improves with repeated use of the affected muscles (the "warm-up" effect). Other symptoms can include muscle weakness, pain, and enlargement (hypertrophy). The severity of the symptoms can vary widely among affected individuals, even among members of the same family. | The hallmark of Myotonia Congenita is muscle stiffness (myotonia) that worsens after periods of rest and improves with repeated use of the affected muscles (the "warm-up" effect). Other symptoms can include muscle weakness, pain, and enlargement (hypertrophy). The severity of the symptoms can vary widely among affected individuals, even among members of the same family. | ||
== Causes == | == Causes == | ||
Myotonia Congenita is caused by mutations in the CLCN1 gene. This gene provides instructions for making a protein that is critical for the normal function of skeletal muscle cells. The CLCN1 protein forms a channel that controls the flow of negatively charged chloride ions into these cells. This ion flow is necessary for the muscle cells to return to a relaxed state after they contract. Mutations in the CLCN1 gene reduce the flow of chloride ions, which makes the muscle cells overly excitable and leads to the prolonged muscle contractions seen in Myotonia Congenita. | Myotonia Congenita is caused by mutations in the CLCN1 gene. This gene provides instructions for making a protein that is critical for the normal function of skeletal muscle cells. The CLCN1 protein forms a channel that controls the flow of negatively charged chloride ions into these cells. This ion flow is necessary for the muscle cells to return to a relaxed state after they contract. Mutations in the CLCN1 gene reduce the flow of chloride ions, which makes the muscle cells overly excitable and leads to the prolonged muscle contractions seen in Myotonia Congenita. | ||
== Diagnosis == | == Diagnosis == | ||
The diagnosis of Myotonia Congenita is based on the clinical symptoms, the family history, and specialized tests that evaluate muscle function. These tests can include electromyography (EMG), which measures the electrical activity of muscle cells, and genetic testing to identify mutations in the CLCN1 gene. | The diagnosis of Myotonia Congenita is based on the clinical symptoms, the family history, and specialized tests that evaluate muscle function. These tests can include electromyography (EMG), which measures the electrical activity of muscle cells, and genetic testing to identify mutations in the CLCN1 gene. | ||
== Treatment == | == Treatment == | ||
There is currently no cure for Myotonia Congenita, but the symptoms can often be managed with medication. Drugs that are commonly used include mexiletine, phenytoin, and carbamazepine, which help to reduce muscle stiffness. Physical therapy can also be beneficial. | There is currently no cure for Myotonia Congenita, but the symptoms can often be managed with medication. Drugs that are commonly used include mexiletine, phenytoin, and carbamazepine, which help to reduce muscle stiffness. Physical therapy can also be beneficial. | ||
== See Also == | == See Also == | ||
* [[Neuromuscular disease]] | * [[Neuromuscular disease]] | ||
* [[Muscular Dystrophy]] | * [[Muscular Dystrophy]] | ||
* [[Genetic disorder]] | * [[Genetic disorder]] | ||
== References == | == References == | ||
<references /> | <references /> | ||
[[Category:Neuromuscular disorders]] | [[Category:Neuromuscular disorders]] | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Rare diseases]] | [[Category:Rare diseases]] | ||
{{stub}} | {{stub}} | ||
{{dictionary-stub1}} | {{dictionary-stub1}} | ||
{{No image}} | {{No image}} | ||
Latest revision as of 03:31, 4 April 2025
| Myotonia congenita | |
|---|---|
| Synonyms | Thomsen disease, Becker disease |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Muscle stiffness, difficulty relaxing muscles |
| Complications | N/A |
| Onset | Childhood or adolescence |
| Duration | Lifelong |
| Types | N/A |
| Causes | Mutations in the CLCN1 gene |
| Risks | Family history |
| Diagnosis | Clinical examination, genetic testing |
| Differential diagnosis | Myotonic dystrophy, paramyotonia congenita |
| Prevention | N/A |
| Treatment | Physical therapy, medication such as mexiletine |
| Medication | N/A |
| Prognosis | N/A |
| Frequency | Rare |
| Deaths | N/A |
Myotonia Congenita is a neuromuscular disorder characterized by the slow relaxation of the muscles after voluntary contraction or electrical stimulation. This condition is present from early childhood, but symptoms can be mild. Myotonia Congenita is caused by mutations in the CLCN1 gene and can be inherited in an autosomal dominant or autosomal recessive manner.
Signs and Symptoms[edit]
The hallmark of Myotonia Congenita is muscle stiffness (myotonia) that worsens after periods of rest and improves with repeated use of the affected muscles (the "warm-up" effect). Other symptoms can include muscle weakness, pain, and enlargement (hypertrophy). The severity of the symptoms can vary widely among affected individuals, even among members of the same family.
Causes[edit]
Myotonia Congenita is caused by mutations in the CLCN1 gene. This gene provides instructions for making a protein that is critical for the normal function of skeletal muscle cells. The CLCN1 protein forms a channel that controls the flow of negatively charged chloride ions into these cells. This ion flow is necessary for the muscle cells to return to a relaxed state after they contract. Mutations in the CLCN1 gene reduce the flow of chloride ions, which makes the muscle cells overly excitable and leads to the prolonged muscle contractions seen in Myotonia Congenita.
Diagnosis[edit]
The diagnosis of Myotonia Congenita is based on the clinical symptoms, the family history, and specialized tests that evaluate muscle function. These tests can include electromyography (EMG), which measures the electrical activity of muscle cells, and genetic testing to identify mutations in the CLCN1 gene.
Treatment[edit]
There is currently no cure for Myotonia Congenita, but the symptoms can often be managed with medication. Drugs that are commonly used include mexiletine, phenytoin, and carbamazepine, which help to reduce muscle stiffness. Physical therapy can also be beneficial.
See Also[edit]
References[edit]
<references />



